Model-based insulin sensitivity as a sepsis diagnostic in critical care

Journal of Diabetes Science and Technology

Volumn 2, Issue 3, 2008, Pages 468-477

  Blakemore, Amy ^a   Wang, Sheng Hui ^b   Compte, Aaron Le ^a   Shaw, Geoffrey M ^c   Wong, Xing Wei ^a   Lin, Jessica ^a   Lotz, Thomas ^a   Hann, Christopher E ^a   Chase, J Geoffrey ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Blood glucose; Critical care; Diagnosis; Hyperglycemia; ICU; Insulin sensitivity retrospective studies; Sepsis; SPRINT

Indexed keywords

EID: 70349758010     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200317     Document Type: Article

References (34)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10.
2. Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Clin Chem. 2004;50(8):1301-14.
3. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858-73.
4. Chase J, Shaw G, Le Compte A, Lee D, Lonergan T, Willacy M, Wong X, Lin J, Lotz T, Hann C. Tight glycaemic control in critical care using insulin and nutrition-the SPRINT Protocol. 6th Annual Diabetes Technology Society Meeting, Atlanta, GA; 2006.
5. Lonergan T, Compte AL, Willacy M, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Wong XW. A pilot study of the SPRINT protocol for tight glycemic control in critically ill patients. Diabetes Technol Ther. 2006;8(4):449-62.
6. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-7.
7. Krinsley JS. Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Crit Care Med. 2003;31:A19.
8. Chase J, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE. Modelbased glycaemic control in critical care - a review of the state of the possible. Biomed Signal Processing Control. 2006;1:3-21.
9. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61.
10. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
11. Bridges EJ, Dukes S. Cardiovascular aspects of septic shock: pathophysiology, monitoring, and treatment. Crit Care Nurse. 2005;25(2):14-6, 18-20, 22-4 passim; quiz 41-2.
12. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-77.
13. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endorcinol Metab. 2000;85(10):3770-8.
14. Chambrier C, Laville M, Rhzioual Berrada K, Odeon M, Boulétreau P, Beylot M. Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond). 2000;99(4):321-8.
15. Rusavy Z, Macdonald IA, Sramek V, Lacigova S, Tesinsky P, Novak I. Glycemia influences on glucose metabolism in sepsis during hyperinsulinemic clamp. JPEN J Parenter Enteral Nutr. 2005;29(3):171-5.
16. Virkamäki A, Yki-Järvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology. 1994;134(5):2072-8.
17. Krogh-Madsen R, Møller K, Dela F, Kronborg G, Jauffred S, Pedersen BK. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab. 2004;286(5):E766-72.
18. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J. 1997;321(Pt 3):707-12.
19. Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab. 2007;292(3):E654-67.
20. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30(5):748-56.
21. Wong XW, Singh-Levett I, Hollingsworth LJ, Shaw GM, Hann CE, Lotz T, Lin J, Wong OS, Chase JG. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther. 2006;8(2):174-90.
22. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Lotz T, Wake GC, Broughton B. Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther. 2005;7(2):274-82.
23. Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther. 2006;8(2):191-206.
24. Shaw GM, Chase JG, Wong J, Lin J, Lotz T, Le Compte AJ, Lonergan TR, Willacy MB, Hann CE. Rethinking glycaemic control in critical illness-from concept to clinical practice change. Crit Care Resusc. 2006;8(2):90-9.
25. Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integralbased parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed. 2005;77(3):259-70.
26. Doran CV. Modelling and control of hyperglycemia in critical care patients. Mechanical Engineering Christchurch, New Zealand: University of Canterbury; 2004.
27. Doran CV, Chase JG, Shaw GM, Moorhead KT, Hudson NH. Automated insulin infusion trials in the intensive care unit. Diabetes Technol Ther. 2004;6(2):155-65.
28. Lin J, Lee DS, Chase JG, Hann CE, Lotz T, Wong, XW. Stochastic modelling of insulin sensitivity variability in critical care. Biomed Signal Processing Control. 2006;1:229-42.
29. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-74.
30. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6.
31. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-10.
32. Arkray, Glucocard TM test strip 2 data sheet. Japan: Arkray Inc.; 2001.
33. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care. 2006;29(2):271-6.
34. Shulman R, Finney SJ, O'Sullivan C, Glynne PA, Greene R. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Crit Care. 2007;11(4):R75.